QuantHealth

QuantHealth

AI-driven clinical trial simulation platform

Overview

Summary of QuantHealth: 1) What it does: QuantHealth uses an AI-powered platform to simulate clinical trials at scale, helping pharmaceutical companies and CROs de-risk and accelerate drug development. 2) How it works: It builds digital twins of patients from large datasets (over 350 million electronic health records, genomic data, and trial data) and runs virtual trials to predict how a real drug would perform, enabling evaluation of efficacy across many trial variations before real-world testing. 3) How it differs from competitors: It combines extensive real-world and genomic data to create detailed patient models (digital twins) and focuses on trial design optimization, patient subgroup identification, and rescuing underperforming trials, offering more data-driven insights than traditional methods. 4) Goal: To cut both the time and cost of bringing new drugs to market while increasing the chances of trial success for pharma companies and CROs.

About QuantHealth

Simplify's Rating
Why QuantHealth is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Data & Analytics

AI & Machine Learning

Healthcare

Company Size

51-200

Company Stage

Series A

Total Funding

$22M

Headquarters

Tel Aviv-Yafo, Israel

Founded

2020

Simplify Jobs

Simplify's Take

What believers are saying

  • Serves twelve of the top 20 global pharmaceutical companies.
  • Validation across 600+ completed trials supports broader enterprise adoption.
  • Sanofi Ventures backing strengthens credibility for additional biopharma partnerships.

What critics are saying

  • Accuracy slippage quickly destroys buyer trust and pilot conversion.
  • Large pharma concentration makes losing one top account materially damaging.
  • Data-access restrictions can degrade model coverage and slow refresh cycles.

What makes QuantHealth unique

  • Proprietary clinical-trial simulation uses digital twins and real-world patient data.
  • New competitive-positioning tools extend beyond protocol design into market-success planning.
  • Platform spans protocol optimization, enrollment forecasting, indication selection, and portfolio prioritization.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$22M

Below

Industry Average

Funded Over

4 Rounds

Series A funding typically happens when a startup has a product and some customers, and now needs funding to scale. This money is usually used to grow the team, expand marketing, and improve the product. Venture capital firms are frequently the main investors here.
Series A Funding Comparison
Below Average

Industry standards

$15M
$2M
QuantHealth
$5M
ByteDance
$8.2M
Discord
$15M
Canva
$30M
Kalshi

Benefits

Health Insurance

401(k) Retirement Plan

Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

2%

1 year growth

2%

2 year growth

2%
Yahoo Finance
Mar 9th, 2026
QuantHealth achieves 8x revenue growth with AI clinical trial simulations for $5B in pharma R&D

QuantHealth, an AI-driven clinical trial simulation company, has reported 8x sales growth through new and expanding engagements with life sciences organisations, representing $5 billion in active R&D investments. The Tel Aviv-based company nearly doubled its clinical trial simulations to over 600 trials in 2025, achieving up to 90% accuracy across nearly 50 therapeutic areas, including oncology, respiratory, immunology and cardiometabolic diseases. QuantHealth's AI-powered platform uses biological and clinical data to help pharmaceutical and biotechnology companies improve clinical trial success rates. The technology addresses a significant industry challenge, as an estimated 90% of drugs fail in clinical trials, costing the pharmaceutical industry more than $50 billion annually. The company's simulations help identify promising drug candidates and predict patient responses to treatment.

Healthcare IT Today
Nov 3rd, 2025
Sanofi Invests $30M in QuantHealth AI

Sanofi and QuantHealth have partnered to enhance AI-powered digital twins and clinical trial simulations, aiming to speed up drug development. Sanofi Ventures has made a strategic investment in QuantHealth, raising its total funding to $30 million. QuantHealth's platform uses real-world data and AI to simulate clinical trials, generating millions of digital twins to predict outcomes and optimize trial design, improving success rates, timelines, and cost efficiency.

Business Wire
Oct 4th, 2025
QuantHealth Secures Strategic Investment from Sanofi Ventures to Accelerate AI-Driven Clinical Trials

QuantHealth, a pioneer in AI-driven clinical trial simulation, announced a strategic investment from Sanofi Ventures, the venture capital arm of global healt...

Barchart
Oct 1st, 2025
QuantHealth Raises $30M from Sanofi Ventures

QuantHealth, an AI-driven clinical trial simulation company, has secured a strategic investment from Sanofi Ventures, the venture capital arm of Sanofi. This investment will help accelerate QuantHealth's efforts in using digital twin technologies for drug development, bringing its total funds raised to $30 million. The partnership aims to enhance clinical trial design and success rates through AI and real-world data.

Health Technology Insights
May 9th, 2025
QuantHealth Launches First Pharmaco-Clinical AI Model for Life Sciences

QuantHealth, an AI-powered clinical trial simulation company, unveiled its Large Real-World Drug Model, a first-of-its-kind clinical trial foundation model that can process and utilize data from more than 100 million patients and billions of therapeutic datapoints in a single simulation.

Recently Posted Jobs

Sign up to get curated job recommendations

QuantHealth is Hiring for 1 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →